| Benefit from B-lymphocyte depletion using the anti-CD20 antibody rituximab in chronic fatigue syndrome. A double-blind and placebo-controlled study Ø Fluge, O Bruland, K Risa, A Storstein, EK Kristoffersen, D Sapkota, ... PloS one 6 (10), e26358, 2011 | 300 | 2011 |
| Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome Ø Fluge, O Mella, O Bruland, K Risa, SE Dyrstad, K Alme, IG Rekeland, ... JCI insight 1 (21), 2016 | 186 | 2016 |
| Human papilloma virus, herpes simplex virus and epstein barr virus in oral squamous cell carcinoma from eight different countries J Jalouli, MM Jalouli, D Sapkota, SO Ibrahim, PA Larsson, L Sand Anticancer research 32 (2), 571-580, 2012 | 176 | 2012 |
| B-lymphocyte depletion in myalgic encephalopathy/chronic fatigue syndrome. An open-label phase II study with rituximab maintenance treatment Ø Fluge, K Risa, S Lunde, K Alme, IG Rekeland, D Sapkota, ... PloS one 10 (7), e0129898, 2015 | 164 | 2015 |
| Prevalence of viral (HPV, EBV, HSV) infections in oral submucous fibrosis and oral cancer from India J Jalouli, SO Ibrahim, R Mehrotra, MM Jalouli, D Sapkota, PA Larsson, ... Acta oto-laryngologica 130 (11), 1306-1311, 2010 | 119 | 2010 |
| MicroRNAs as important players and biomarkers in oral carcinogenesis A Min, C Zhu, S Peng, S Rajthala, DE Costea, D Sapkota BioMed research international 2015, 2015 | 114 | 2015 |
| COVID-19 salivary signature: diagnostic and research opportunities D Sapkota, TM Søland, HK Galtung, LP Sand, S Giannecchini, KKW To, ... Journal of Clinical Pathology 74 (6), 344-349, 2021 | 101 | 2021 |
| Presence of human papilloma virus, herpes simplex virus and Epstein–Barr virus DNA in oral biopsies from Sudanese patients with regard to toombak use J Jalouli, SO Ibrahim, D Sapkota, MM Jalouli, EN Vasstrand, JM Hirsch, ... Journal of oral pathology & medicine 39 (8), 599-604, 2010 | 85 | 2010 |
| S100A14 regulates the invasive potential of oral squamous cell carcinoma derived cell-lines in vitro by modulating expression of matrix metalloproteinases, MMP1 and MMP9 D Sapkota, O Bruland, DE Costea, H Haugen, EN Vasstrand, SO Ibrahim European Journal of Cancer 47 (4), 600-610, 2011 | 63 | 2011 |
| Metabolic reprogramming of normal oral fibroblasts correlated with increased glycolytic metabolism of oral squamous cell carcinoma and precedes their activation into carcinoma … Z Zhang, Z Gao, S Rajthala, D Sapkota, H Dongre, H Parajuli, S Suliman, ... Cellular and Molecular Life Sciences 77, 1115-1133, 2020 | 54 | 2020 |
| Expression profile of the S100 gene family members in oral squamous cell carcinomas D Sapkota, O Bruland, OE Bøe, H Bakeer, OAA Elgindi, EN Vasstrand, ... Journal of oral pathology & medicine 37 (10), 607-615, 2008 | 50 | 2008 |
| Delivery of VEGFA in bone marrow stromal cells seeded in copolymer scaffold enhances angiogenesis, but is inadequate for osteogenesis as compared with the dual delivery of … S Sharma, D Sapkota, Y Xue, S Rajthala, MA Yassin, A Finne-Wistrand, ... Stem cell research & therapy 9, 1-13, 2018 | 48 | 2018 |
| S100A14 inhibits proliferation of oral carcinoma derived cells through G1-arrest D Sapkota, DE Costea, M Blø, O Bruland, JB Lorens, EN Vasstrand, ... Oral oncology 48 (3), 219-225, 2012 | 47 | 2012 |
| S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma D Sapkota, O Bruland, H Parajuli, TA Osman, MT Teh, AC Johannessen, ... BMC cancer 15, 1-14, 2015 | 45 | 2015 |
| Performance of at-home self-collected saliva and nasal-oropharyngeal swabs in the surveillance of COVID-19 PH Braz-Silva, AC Mamana, CM Romano, AC Felix, AV de Paula, ... Journal of oral microbiology 13 (1), 1858002, 2021 | 43 | 2021 |
| Saliva testing for COVID-19? D Sapkota, SB Thapa, B Hasséus, JL Jensen British dental journal 228 (9), 658-659, 2020 | 32 | 2020 |
| S100A14 interacts with S100A16 and regulates its expression in human cancer cells D Sapkota, DE Costea, SO Ibrahim, AC Johannessen, O Bruland PLoS One 8 (9), e76058, 2013 | 27 | 2013 |
| Serum BAFF and APRIL Levels, T-lymphocyte subsets, and immunoglobulins after B-cell depletion using the monoclonal anti-CD20 antibody rituximab in myalgic encephalopathy … S Lunde, EK Kristoffersen, D Sapkota, K Risa, O Dahl, O Bruland, O Mella, ... PLoS One 11 (8), e0161226, 2016 | 25 | 2016 |
| Expression profile and functional role of S100A14 in human cancer S Basnet, S Sharma, DE Costea, D Sapkota Oncotarget 10 (31), 2996, 2019 | 24 | 2019 |
| A tyrosine kinase-activating variant Asn666Ser in PDGFRB causes a progeria-like condition in the severe end of Penttinen syndrome C Bredrup, T Stokowy, J McGaughran, S Lee, D Sapkota, I Cristea, L Xu, ... European Journal of Human Genetics 27 (4), 574-581, 2019 | 24 | 2019 |
